European School of Haematology
ESH host multiple events throughout the year focusing on different areas of hematology. These include conferences covering translational research and others centered around diagnosis and treatment of specific malignancies.
Filter by content:
Types
Chromosomal aberrations
Deletion 17p
High-risk
MGRS
MGUS
MM-related mutations
Newly diagnosed multiple myeloma
Plasma cell dyscrasias
Plasma cell leukemia
Relapsed/refractory multiple myeloma
Risk
Smoldering multiple myeloma
Solitary plasmacytoma
TP53
Translocation (4;14)
Therapeutics
Auto-HSCT
BCMA CAR-T
Belantamab mafodotin
Bortezomib
CAR therapy
Carfilzomib
Checkpoint inhibitors
Clodronate
Daratumumab
Denosumab
Dexamethasone
Doxorubicin
Elotuzumab
Elranatamab
Immune modulators
Isatuximab
Ixazomib
Lenalidomide
Melphalan
Pomalidomide
Prednisone
Proteasome inhibitors
Selinexor
T-cell engagers
Teclistamab
Thalidomide
Vaccines
Venetoclax
Vincristine
Zoledronic acid
Congresses
2021 Symposium
ASCO 2019
ASH 2017
ASH 2019
EBMT 2019
ESH 2017
ESH 2018
ESH 2019
ESH 2020
ESH 2021
ESH 2024
Trials
ALCYONE
CASSIOPEIA
DREAMM-7
DREAMM-8
Expert Opinions
Brea Lipe
Chengcheng Fu
Cristina Nanni
Daniel Auclair
Enrique Ocio
Gareth Morgan
Hermann Einsele
Hervé Avet-Loiseau
Irene Ghobrial
Jesus G. Berdeja
María-Victoria Mateos
Martin F. Kaiser
Meletios Dimopoulos
Mohamad Mohty
Nico Gagelmann
Niels van de Donk
Nina Shah
Ola Landgren
Philippe Moreau
Rakesh Popat
Saad Usmani
Sagar Lonial
Shaji Kumar
Sonja Zweegman
Stefan Knop
Xavier Leleu
Educational Resources
Diagnostic and treatment guidelines
Multiple Myeloma Hub symposiums
Special populations